Enigma Diagnostics secures additional Technology Strategy Board funding for MDR-TB assay

Enigma Diagnostics
March 12, 2014, 8:51 p.m.

Enigma Diagnostics, a leader in molecular diagnostic point-of-care infectious disease testing, announces that it has been awarded a second grant from the UK’s innovation agency, the Technology Strategy Board. This grant will support further development of its test for multidrug-resistant tuberculosis (MDR-TB) on its CE Marked Enigma® Mini Laboratory (ML) system.

Read the full press release here.

Source: Enigma Diagnostics